Description
Uses of Medicine:
Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg is an antineoplastic drug that falls under the class of medicines known as androgen receptor inhibitors. Patients, Healthcare Professionals (HCPs), or Hospitals can buy Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg online from India through THE INDIAN PHARMA (a trusted Enzalutamide Supplier, Exporter, and Contract Manufacturer in India) for the management and treatment of patients with:- castration-resistant prostate cancer (CRPC).
- metastatic castration-sensitive prostate cancer (mCSPC).
- non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis.
Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg are used in patients who are not responsive to surgical or hormonal therapies. This medication is intended to stop the growth of unhealthy cells by obstructing signal transmissions. However, you should not take it if you have an allergy to any components of the capsule. A physician or oncologist may ask you to carry out some tests during treatment; it may include blood tests, like PSA tests, to evaluate the efficacy of the treatment. Such tests assess the quantity of a protein termed PSA produced by the prostate gland, an organ often afflicted by cancers in older males. They may also perform liver function tests alongside a CBC to rule out other complications.
Taking Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg can cause seizures. So, individuals with a known history of seizures should be careful. It is not advisable to eat grapefruit or drink grapefruit juice while receiving treatment with this medicine. Grapefruit can be responsible for increasing the levels of the medicine in the body. This may lead to unwanted side effects. Enzalutamide is not safe for use during pregnancy because it can cause harm to an unborn baby. This medicine can also cause fertility complications, so it’s important to let your doctor know if you have concerns about fertility before initiating treatment.
Contraceptive measures for both men and women are required during the treatment period and for 3 months following completion of Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg therapy. This is to prevent the possibility of the drug interfering with pregnancy. Inform your physician if you are already expecting a child or if you intend to have a baby shortly before initiating treatment. As with any medical issue, adhere to the guidance of your physician and inquire for clarification on any aspects of the treatment plan that may be unclear.
Dosage & Side Effects:
The recommended dosage of Enzalutamide is 160 mg administered orally once daily with or without food until there is evidence of disease progression or unacceptable toxicity. It is advisable to take each capsule or tablet whole with an adequate amount of water to make sure that all medicine is successfully swallowed. It is not advisable to chew, dissolve, or open the capsules. Never cut, crush, or chew the oral tablets. Patients with CRPC or mCSPC receiving treatment with Enzalutamide should also receive a gonadotropic-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy. Patients with nmCSPC with high-risk BCR may be treated with Enzalutamide with or without a GnRH analog.The most common side effects of Enzalutamide Capsules: 40 mg & Tablets: 40 mg/80 mg are musculoskeletal pain, diarrhea, fall, fatigue, hot flush, hypertension, constipation, decreased appetite, fracture, hemorrhage, and headache.
